Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-cell non-Hodgkin's lymphoma

Andre Goy*, Anas Younes, Peter McLaughlin, Barbara Pro, Jorge E. Romaguera, Frederick Hagemeister, Luis Fayad, Nam H. Dang, Felipe Samaniego, Michael Wang, Kristine Broglio, Barry Samuels, Frederic Gilles, Andreas H. Sarris, Susan Hart, Elizabeth Trehu, David Schenkein, Fernando Cabanillas, Alma M. Rodriguez

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

493 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-cell non-Hodgkin's lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences